Recent updates on novel therapeutic targets of cardiovascular diseases

Area of Science:

• Cardiology
• Pharmacology
• Biomedical Research

Background:

• Cardiovascular diseases (CVDs) represent the leading global cause of mortality, accounting for 17.7 million deaths in 2015.
• Cardiac disorders are associated with substantial healthcare expenditures, surpassing those for conditions like diabetes and Alzheimer's.
• Oxidative stress and inflammation are critical contributors to atherosclerosis and subsequent cardiovascular events like myocardial infarction.

Purpose of the Study:

• To review novel therapeutic strategies and drug targets for cardiovascular diseases.
• To discuss recent advancements in pharmacological interventions for various cardiac conditions.
• To provide a comprehensive overview of the mechanism of action and clinical pharmacology of emerging cardiovascular drugs.

Main Methods:

• Literature review of recent studies on cardiovascular drug discovery.
• Analysis of animal studies identifying potential drug targets.
• Evaluation of clinical data for novel therapeutic agents.

Main Results:

• Multiple drug targets for cardiovascular disorders have been identified from preclinical research.
• Several novel drugs have demonstrated efficacy in treating hypertension, heart failure, arrhythmia, and angina.
• Despite promising preclinical findings, clinical translation and approval of new cardiovascular agents remain limited.

Conclusions:

• Novel therapeutic strategies are emerging for cardiovascular diseases, driven by research into drug targets and mechanisms.
• A comprehensive understanding of the pharmacology of new drugs is crucial for effective clinical application.
• Continued research and clinical evaluation are necessary to address the unmet needs in cardiovascular disease treatment.